Literature DB >> 18976320

Antiepileptic monotherapy significantly impairs normative scores on common tests of executive functions.

E Hessen1, M I Lossius, L Gjerstad.   

Abstract

BACKGROUND: Understanding how antiepileptic (AED) monotherapy influences normative test scores is of importance in the clinic for correct interpretation of neuropsychological profiles. Previous studies have primarily reported minor influence on neuropsychological raw scores, and the clinical relevance of these findings is unclear. AIM OF THE STUDY: To obtain a clinical valid answer to this question, we analysed changes in T-scores after AED withdrawal in a large group of well-controlled epilepsy patients, for tests previously shown to be sensitive to AED withdrawal.
METHODS: We report outcomes on measures of choice reaction time from the California Computerized Assessment Package, on the Controlled Oral Word Association Test and on the Stroop Color-Word Interference Test.
RESULTS: Significantly improved T-scores were revealed after AED withdrawal on five of the six tests of executive functions with mean improvement of 5 T-scores. Comparable results were achieved in the subgroup taking carbamazepine, with a mean improvement of 6.2 T-scores.
CONCLUSION: The present results suggest that T-scores for computerized tests of choice reaction time and tests of verbal fluency and response inhibition may be significantly impaired as a consequence of AED monotherapy, and that careful interpretation of these scores is required in diagnostic assessment of patients receiving AED monotherapy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18976320     DOI: 10.1111/j.1600-0404.2008.01109.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  7 in total

1.  The cognitive impact of antiepileptic drugs.

Authors:  Clare M Eddy; Hugh E Rickards; Andrea E Cavanna
Journal:  Ther Adv Neurol Disord       Date:  2011-11       Impact factor: 6.570

2.  Executive functions in chronic mesial temporal lobe epilepsy.

Authors:  Laura Zamarian; Eugen Trinka; Elisabeth Bonatti; Giorgi Kuchukhidze; Thomas Bodner; Thomas Benke; Florian Koppelstaetter; Margarete Delazer
Journal:  Epilepsy Res Treat       Date:  2011-03-06

3.  Polypharmacy in patients with epilepsy: A nationally representative cross-sectional study.

Authors:  Samuel W Terman; Carole E Aubert; Chloe E Hill; Donovan T Maust; John P Betjemann; Cynthia M Boyd; James F Burke
Journal:  Epilepsy Behav       Date:  2020-07-03       Impact factor: 2.937

4.  Reappraisal of the Medical Research Council Antiepileptic Drug Withdrawal Study: Contamination-adjusted and dose-response re-analysis.

Authors:  Samuel W Terman; Chang Wang; Lu Wang; Kees P J Braun; Willem M Otte; Geertruida Slinger; Wesley T Kerr; Morten I Lossius; Laura Bonnett; James F Burke; Anthony Marson
Journal:  Epilepsia       Date:  2022-05-18       Impact factor: 6.740

5.  Incidence of and predictors for antiseizure medication gaps in Medicare beneficiaries with epilepsy: a retrospective cohort study.

Authors:  Samuel W Terman; Joshua D Niznik; Geertruida Slinger; Willem M Otte; Kees P J Braun; Carole E Aubert; Wesley T Kerr; Cynthia M Boyd; James F Burke
Journal:  BMC Neurol       Date:  2022-09-01       Impact factor: 2.903

Review 6.  Optogenetics and its application in neural degeneration and regeneration.

Authors:  Josue D Ordaz; Wei Wu; Xiao-Ming Xu
Journal:  Neural Regen Res       Date:  2017-08       Impact factor: 5.135

7.  Risky Decision Making in Juvenile Myoclonic Epilepsy.

Authors:  Iris Unterberger; Laura Zamarian; Manuela Prieschl; Melanie Bergmann; Gerald Walser; Gerhard Luef; Andrija Javor; Gerhard Ransmayr; Margarete Delazer
Journal:  Front Neurol       Date:  2018-03-26       Impact factor: 4.003

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.